Expertise in
42
conditions

Dr. Jan E. Duus

Hematology | Oncology
CVPH Medical Center
75 Beekman St, 
Plattsburgh, NY 
Expertise in
42
conditions
CVPH Medical Center
75 Beekman St, 
Plattsburgh, NY 

Overview

Jan Duus is a Hematologist and an Oncologist practicing medicine in Plattsburgh, New York.

Dr. Duus is highly rated in 42 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), Non-Hodgkin Lymphoma, and Bone Marrow Aspiration.

He is actively involved in clinical research, participating in 6 clinical trials.

Specialties

Hematology
Oncology

Licenses

Internal Medicine in NY

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO

Locations

CVPH Medical Center
75 Beekman St, Plattsburgh, NY 12901

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 02, 2026
Intervention Type: Other
Study Phase: Phase 3
Randomized Phase II Open Label Study of Lenalidomide R-CHOP (R2CHOP) vs. RCHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) in Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma
Randomized Phase II Open Label Study of Lenalidomide R-CHOP (R2CHOP) vs. RCHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) in Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Drug, Biological, Other
Study Drugs: Cyclophosphamide, Doxorubicin Hydrochloride, Lenalidomide, Prednisone, Rituximab, Vincristine Sulfate
Study Phase: Phase 2
Randomized Phase III Trial of Lenalidomide Versus Observation Alone in Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Randomized Phase III Trial of Lenalidomide Versus Observation Alone in Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Enrollment Status: Active_not_recruiting
Publish Date: August 04, 2026
Intervention Type: Other, Drug
Study Drug: Lenalidomide
Study Phase: Phase 3
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: May 06, 2026
Intervention Type: Drug, Other
Study Drugs: Carboplatin, Cyclophosphamide, Doxorubicin Hydrochloride, Paclitaxel
Study Phase: Phase 3
Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy - The C-TRACT Trial
Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy - The C-TRACT Trial
Enrollment Status: Active_not_recruiting
Publish Date: January 28, 2026
Intervention Type: Device
Study Phase: Not Applicable
Randomized Phase III Trial of Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide, and Dexamethasone (CRd) Followed by Limited or Indefinite Duration Lenalidomide Maintenance in Patients With Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)
Randomized Phase III Trial of Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide, and Dexamethasone (CRd) Followed by Limited or Indefinite Duration Lenalidomide Maintenance in Patients With Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)
Enrollment Status: Active_not_recruiting
Publish Date: September 08, 2025
Intervention Type: Other, Drug
Study Drugs: Bortezomib, Carfilzomib, Dexamethasone, Lenalidomide
Study Phase: Phase 3
View 5 Less Clinical Trials
Similar Doctors
Expertise in
6
conditions
Dr. Mary Cushman
Hematology
Expertise in
6
conditions
Dr. Mary Cushman
Hematology
Referral may be required

University Of Vermont Medical Center

111 Colchester Ave, 
Burlington, VT 
 (20.4 miles away)
802-847-8400
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Mary Cushman is a Hematologist practicing medicine in Burlington, Vermont. Dr. Cushman is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Venous Thromboembolism (VTE), Mesenteric Venous Thrombosis, Deep Vein Thrombosis, Embolectomy, and Hormone Replacement Therapy (HRT). Dr. Cushman is currently accepting new patients.

Expertise in
10
conditions
Dr. David M. Mastrianni
Hematology | Oncology
Expertise in
10
conditions
Dr. David M. Mastrianni
Hematology | Oncology
Referral may be required

Adirondack Health

2233 State Route 86, 
Saranac Lake, NY 
 (41.2 miles away)
518-891-4141
Languages Spoken:
English
See accepted insurances
Offers Telehealth

David Mastrianni is a Hematologist and an Oncologist practicing medicine in Saranac Lake, New York. Dr. Mastrianni is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Cervical Cancer, Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, and Adult Immune Thrombocytopenia.

Expertise in
11
conditions
Expertise in
11
conditions
Referral may be required

University Of Vermont Medical Center

111 Colchester Ave, 
Burlington, VT 
 (20.4 miles away)
802-847-8400
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Neil Zakai is a Hematologist practicing medicine in Burlington, Vermont. Dr. Zakai is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Venous Thromboembolism (VTE), Mesenteric Venous Thrombosis, Antiphospholipid Syndrome, Deep Vein Thrombosis, and Bone Marrow Aspiration. Dr. Zakai is currently accepting new patients.

Frequently Asked Questions about Dr. Jan E. Duus

How do I make an appointment with Dr. Jan E. Duus?

You can book an appointment with Dr. Jan E. Duus by calling their office at 518-562-7110. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jan E. Duus a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jan E. Duus is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jan E. Duus specialize in?

While Dr. Jan E. Duus is a Hematology, they have specific expertise in Lung Cancer, Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Jan E. Duus accept my insurance?

Dr. Jan E. Duus accepts most major insurance plans, including Aetna and Cigna. We recommend calling the office directly at 518-562-7110 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Duus's expertise for a condition
ConditionClose
    View All 12 Distinguished Conditions
    View All 30 Advanced Conditions
    View All 101 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile